Recycling is impractical and, according to Greenpeace, most plastics in the recycle bin are going to landfills.1 The report pulled data from Bennington College’s Beyond Plastics report2 released May 2022. Researchers from the college revealed that the amount of plastic recycled had dropped to a new low of between 5% and 6% — and that… Read More »
Agreement delivers Okta’s identity-first Zero Trust security solution to the channel—a vital security tool in an era of remote work LONDON, UK – 24 November – Westcon-Comstor, global technology provider and specialist distributor, today announced it has signed a new distribution agreement with Okta, the leading independent identity provider. The partnership will bring Okta’s identity-first… Read More »
The contract extends SANDSIV and Poste Italiane’s collaboration for an additional three years, highlighting SANDSIV’s commitment to security and compliance ZURICH, Switzerland (November, 24 2022)—SANDSIV, the global leader in Customer Experience Management (CXM) and Voice of the Customer (VoC) enterprise solutions, has been awarded a three-year contract with Poste Italiane, Italy’s leading postal, banking, financial… Read More »
Samsung partners with top digital studio to bring global phenomenon 5-Minute Crafts® and animated brand TeenVee to European television devices London, 23 November 2022 – TheSoul Publishing today announced its partnership with Samsung to bring several of TheSoul’s globally popular brands to Samsung TV Plus in key European territories. With the leading TV manufacturer’s service… Read More »
By now, you’re probably aware that one of the lethal effects of COVID-19 is the virus’ ability to trigger a cytokine storm. It makes sense then that many health practitioners are looking at ways to strengthen and improve immune function. The good news is there are several strategies that appear very helpful in this respect.… Read More »
The manufactured COVID pandemic has been a proverbial golden egg-laying goose for Pfizer. Its annual revenue is expected to reach $ 101.3 billion in 2022,1 thanks to its COVID jab, which doesn’t prevent infection or spread, and Paxlovid, an ineffective and dangerous COVID antiviral that causes rebound. It would be comical if it weren’t so… Read More »